Globus Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,101	2,939	2,519	1,568	1,023	958.1
Revenue Growth (YoY)	23.49%	16.65%	60.62%	53.34%	6.76%	21.43%
Cost of Revenue	996.47	957.8	1,035	548.17	263.73	239.22
Gross Profit	2,104	1,981	1,484	1,020	759.12	718.88
Selling, General & Admin	1,233	1,178	981.36	643.84	432.12	408.15
Depreciation & Amortization Expenses	118.92	118.19	119.37	51.03	17.74	18.53
Research & Development	150.69	147.25	163.75	124.01	73.02	97.35
Other Operating Expenses	67.91	57.38	53.4	68.27	8.3	22.91
Total Operating Expenses	1,571	1,501	1,318	887.16	531.17	546.93
Operating Income	533.2	479.82	165.99	133.14	227.95	171.95
Total Non-Operating Income (Expense)	125.27	125.25	-45.27	32.25	15.07	8.45
Pretax Income	658.47	605.07	120.72	165.39	243.02	180.41
Provision for Income Taxes	71.77	67.2	17.74	42.52	52.85	31.22
Net Income	586.71	537.87	102.98	122.87	190.17	149.19
Net Income to Common	586.71	537.87	102.98	122.87	190.17	149.19
Net Income Growth	216.18%	422.28%	-16.19%	-35.39%	27.47%	45.86%
Shares Outstanding (Basic)	135	135	136	113	100	101
Shares Outstanding (Diluted)	137	137	138	115	103	104
Shares Change (YoY)	-1.42%	-0.58%	20.27%	11.68%	-0.95%	1.39%
EPS (Basic)	4.35	3.98	0.76	1.09	1.89	1.48
EPS (Diluted)	4.30	3.92	0.75	1.07	1.85	1.44
EPS Growth	220.90%	422.67%	-29.91%	-42.16%	28.47%	8.27%
Free Cash Flow	610.32	588.77	405.21	165.23	104.42	219.38
Free Cash Flow Growth	3.66%	45.30%	145.25%	58.23%	-52.40%	62.34%
Free Cash Flow Per Share	4.47	4.30	2.94	1.44	1.02	2.12
Gross Margin	67.86%	67.41%	58.90%	65.05%	74.22%	75.03%
Operating Margin	17.20%	16.33%	6.59%	8.49%	22.29%	17.95%
Profit Margin	18.92%	18.30%	4.09%	7.83%	18.59%	15.57%
FCF Margin	19.68%	20.03%	16.08%	10.53%	10.21%	22.90%
EBITDA	814.25	756.66	419.38	278.67	296.2	241.82
EBITDA Margin	26.26%	25.75%	16.65%	17.77%	28.96%	25.24%
EBIT	533.2	479.82	165.99	133.14	227.95	171.95
EBIT Margin	17.20%	16.33%	6.59%	8.49%	22.29%	17.95%
Effective Tax Rate	10.90%	11.11%	14.69%	25.71%	21.75%	17.30%

SEC Filings: 10-K · 10-Q